Our Priorities: Research
Our Priorities: Research
Our world-class faculty are breaking new ground in cancer, neuroscience, orthoapaedics, heart and vascular disease, and many other areas. With your support, we can pursue ever-bolder directions in research.
In Landmark Study, Immunotherapy Boosts Survival of Advanced Hodgkin Lymphoma
Wilmot Cancer Institute Director Jonathan Friedberg led the practice-changing research which shows that a treatment that rallies the immune system to destroy cancer raised the survival rate for advanced Hodgkin lymphoma patients to a remarkable 92 percent, suggesting a new standard therapy for the disease.